Coronary Stenting: Everyone should be using FFR Morton J. Kern, MD Chief of Medicine, VA Long Beach HCS Professor of Medicine University California Irvine.

Slides:



Advertisements
Similar presentations
Disclosure Statement of Financial Interest
Advertisements

IVUS Use during Left Main PCI improve Immediate and Long Term Outcome Where is the Evidence? E Murat Tuzcu, MD, FACC Professor of Medicine Vice Chairman.
FFR & IVUS PRIOR TO REVASCULARISATION Journal review Dr. Sony Manuel M Senior Resident MCH Kozhikode.
FFR & IVUS PRIOR TO REVASCULARISATION Journal review Dr.Sony Manuel M Senior Resident MCH Kozhikode.
Coronary stenting: the appropriate use of FFR Morton J. Kern, MD Professor of Medicine Chief of Cardiology LBVA Associate Chief Cardiology University California.
Pitfalls & Practical Tips
FRACTIONAL FLOW RESERVE versus ANGIOGRAPHY
FFR vs Angiography for Multivessel Evaluation
Pros and cons of FFR in multivessel disease: from FAME to ACS Giuseppe Biondi Zoccai University of Modena and Reggio Emilia, Modena, Italy
FAME 2 year Objective:To investigate the 2-year outcome of PCI guided by FFR in patients with multivessel CAD. Study:Multicenter, single blind, randomized.
To stent or not to stent Clinical Utility of Fractional Flow Reserve.
Journal : Evidence Review PCI : Role of FFR Dr Binjo J Vazhappilly SR Cardiology MCH Calicut.
Educational Training Program ESC European Heart House, Nice, April 19 th –21st, 2007 CORONARY PHYSIOLOGY IN THE CATHLAB LONG-TERM CLINICAL OUTCOME OF MILD.
CORONARY PRESSURE MEASURENT AND FRACTIONAL FLOW RESERVE
DEFER STUDY: 5-YEAR FOLLOW-UP A Multicenter Randomized Study
FFR Going Beyond Angiography
PRIMARY Results of ADVISE ADenosine Vasodilation Independent Stenosis Evaluation Dr Justin Davies MD, PhD Imperial College London on behalf of the ADVISE.
COURAGE: Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation Purpose To compare the efficacy of optimal medical therapy (OMT)
FFR vs. Angiography for Multivessel Evaluation FAME 2 Year Follow-Up William F. Fearon, Pim A.L. Tonino, Bernard De Bruyne, Uwe Siebert and Nico H.J. Pijls,
Is FFR a Substitute For Sound Clinical Judgement ? Jeffrey W. Moses, MD Columbia University Medical Center/ NY-Presbyterian Hospital.
Tips and Pitfalls in Measurement of FFR during Bifurcation Stenting Nanjing first hospital Nanjing cardiovascular hospital Yefei Chenshaoliang Zhangjunjie.
Unstable angina and arterial hypertension Leszek Kinasz, MD American Heart of Poland Ustron, Poland.
Multi-vessel disease and intracoronay physiology Combat MI 2009 Kees-joost Botman MD, PhD Catharina hospital Eindhoven Heart Institute The Netherlands.
BURZOTTA F. 1, PAN M. 2 (CO-FIRST AUTHOR), TRANI C. 1, MEDINA A. 3, SUÀREZ DE LEZO J. 2, NICCOLI G. 1, ROMERO M. 2, PORTO I. 1, MAZUELOS F. 2, LEONE A.M.
Jie Qian National Heart Center & FuWai Hospitall FFR in Diffuse Multivessel Disease.
Baisc Concept and Technique of FFR FuWai Hospital JieQian.
Pressure Wire Evaluation of the Left Main Stem Dr Phil MacCarthy Consultant Cardiologist King’s Cardiac Centre Left Main 5+ at AA2007, Jan 24 th, 2007.
Pathophysiology of the coronary circulation: role of FFR Giuseppe Biondi Zoccai University of Modena and Reggio Emilia, Modena, Italy
Cost-Effectiveness of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention in Patients with Stable Coronary Disease: Results from the FAME.
Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial Myeong-Ki.
Is there any role for intravascular ultrasound in bifurcation lesions? Giuseppe Biondi-Zoccai, MD University of Turin, Turin, Italy.
Columbia University Medical Center Cardiovascular Research Foundation New York City, NY Akiko Maehara, MD Use of IVUS Reduces Stent Thrombosis and Myocardial.
Afsane mohammadi,MD Interventional cardiologist.  The presence of inducible ischemia is an important risk factor for adverse outcome.the more inducible.
Survival Benefits in Higher Risk Patients Coronary Revascularization has Revolutionized the Therapy of Ischemic Heart Disease Acute coronary syndromes.
Durable Polymer DES: 5 Year Outcomes RESOLUTE Update Sigmund Silber, MD FESC, FACC, FAHA Heart Center at the Isar Munich, Germany On Behalf of the RESOLUTE.
Simplifying Serial Lesion Assessment
Fractional Flow Reserve: How to use FFR in 2015
Methods for Hyperemic Assessment of FFR
Forget IVUS and OCT; Everyone Should Be Using FFR
New Pressure Wires and Catheters Systems for Measuring FFR:
FFR DECISION MAKING DURING DIAGNOSTIC PROCEDURES
William E. Boden, MD, FACC, FAHA
Use of fractional flow reserve in patients with coronary artery disease: The right choice for the right outcome  Jae Yoon Park, MD, Amir Lerman, MD, Joerg.
Nico H.J. Pijls, William F. Fearon, Peter Jüni, and Bernard De Bruyne
Physiologic Lesion Assessment: Advantages and Pitfalls
Updates From NOTION: The First All-Comer TAVR Trial
Multi Modality Approach to Diagnosis of Ischemia in Post CABG Cases
Quantitative Flow Ratio (QFR)
Clinical Usefulness of Post-Stenting FFR
The Starting Point: Translesional Pressure versus Flow
Solved & Unsolved Issues
Bifurcation FFR - Helpful or Wasteful?
9:00 AM-9:05 AM, Tuesday, Oct. 31; Room 201/203
Physiological Assessment of Left Main Coronary Artery Disease
When IVUS? When FFR? Assessing Intermediate Lesions
Debate: What Does the Future Hold for the Treatment of Unprotected Left Main Disease? More PCI No More Routine Surgery Ron Waksman, MD, FACC Washington.
OCT-Guided PCI What needs to be done to establish criteria?
Fractional Flow Reserve Workshop
Catheter-Based Treatment of Coronary Artery Disease
71 yo Man with typical angina, pos stress, CAD risk factors
3-Year Clinical Outcomes From the RESOLUTE US Study
Comparison of Everolimus- and Biolimus-Eluting Coronary Stents With Everolimus-Eluting Bioresorbable Vascular Scaffolds: 2-year Outcomes of the EVERBIO.
TIMI IIIA Protocol Design 391 Patients with Unstable Angina / NQWMI
FFR vs. Angiography for Multivessel Evaluation FAME 2 Year Follow-Up
Incidence and management of restenosis after treatment of unprotected left main disease with drug-eluting stents: 70 restenotic cases from a cohort of.
FOR DISTRIBUTION BY MEDTRONIC OFFICE OF MEDICAL AFFAIRS ONLY.
Presented at TCT 2006.
ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions J. Mehilli, MD Deutsches Herzzentrum Technische.
Presentation transcript:

Coronary Stenting: Everyone should be using FFR Morton J. Kern, MD Chief of Medicine, VA Long Beach HCS Professor of Medicine University California Irvine Orange, California

Disclosure: Morton J. Kern, MD Within the past 12 months, the presenter or their spouse/partner have had a financial interest/arrangement or affiliation with the organization listed below. Company NameRelationship St. Jude Medical Inc. Speakers’ Bureau Volcano TherapeuticsSpeakers’ Bureau Merit Medical Inc.Consultant Acist Medical Inc.Consultant OpsensConsultant HeartflowConsultant

To treat or not to treat? Is this lesion producing Ischemia? Is PCI appropriate for situation?

Coronary Physiology (FFR as well as FFRCT) is needed because angiography/CTA does not always reflect the functional (i.e. ischemic) impact of a stenosis. LAO, RAO,

Aortic, Pa Coronary, Pd FFR= Pd/Pa = 65/90 = 0.72 Measurement of FFR correlates to the results of stress testing and ischemia out of the lab. FFR is a ‘stress test’ for that artery in the lab at time of cath. Adenosine Resting pressures

Technique Counts: Confounding Factors for FFR 1. Equipment factors: –Erroneous zero –Incomplete pressure transmission (tubing/connector leaks) –Faulty electric wire connection –Pressure signal drift –Hemodynamic recorder miscalibration 2. Procedural factors –Guide catheter damping –Incorrect placement pressure sensor –Inadequate or variable hyperemia 3. Physiological factors –Serial lesion –Reduced myocardial bed –Acute myocardial infarction Theoretical conditions that might influence FFR –Severe left ventricular hypertrophy –Exuberant collateral supply –Adenosine insensitivity

5 Steps to Accurate FFR 1.Zero guide and wire on table to atmosphere 2.Insert wire into guide and match wire/guide pressures in aorta 3.Cross lesion 2-3cm distal 4.Turn on IV adenosine: Use the ‘smart minimum FFR or lowest Pd/Pa 5.Confirm accuracy with pressure pull back

Rely on FFR – No Guide Catheter Side Holes or Damping From Nico Pijls

Notch No notch Rely on FFR – Avoid Signal Drift Drift Drift True Gradient

Pharmacologic Hyperemia IV Adenosine – 140mcg/kg/min IC Adenosine - LCA = mcg bolus - RCA = mcg bolus

When to measure the FFR? Take the lowest value Automated software records the lowest Pd/Pa as the FFR.

Ref Diam (mm) % Stenosis for an Cross Sectional Area of 4 mm² < 4 mm² = significant stenosis ? Q: Why can we not use IVUS/OCT for functional assessment? A: A single cross-sectional area does not mean the same thing everywhere.

FFR Outcome Studies N= Study DesignQuestionOutcomeJournal DEFER ( ) 325Prospective MC RCT Is it safe to defer stenting intermediate lesions with FFR>0.75 Less MACE, med rx when FFR >0.75 JACC FAME ( ) 750Prospective MC RCT Does FFR guided PCI vs. angio guided for MVD improve outcomes? Less MACE*, lower cost w FFR NEJM FAME II (2012) 1,220Prospective MC RCT Does FFR guided PCI + OMT vs. OMT alone improve outcomes? Less MACE w FFR, cost effective NEJM Mayo (2013) 7,358Retro SC Registry Does FFR vs angio-guided PCI improve outcomes in routine practice? Less MACE w FFREHJ R3F (France) (2014) 1.075Prospective MC Registry “”FFR reclass revasc decision in 47% Circulatio n Ripcord FFRCT (UK) (2015) 200Prospective MC Registry “”FFR reclass revasc decision in 36% EHJ, In press Asan FFR (Korea) (2013) Prospective SC Registry “”Fewer stents and less MACE w FFR EHJ FFR Outcome Studies

62 yo Man, RCA stent occl 2yr ago with return of CP LAD FFR=0.86, 0.87 Now 1V CAD and new approach

Kaplan–Meier survival curve for clinical events among 3 groups at 5-y follow-up. Sang Hyun Park et al. Circ Cardiovasc Interv. 2015;8:e002442

71 yo Man with typical angina, pos stress, CAD risk factors What’s your best approach?

FFR CFX FFR CFX=0.88

LAD Xience 3.5x18. 2 nd LAD lesion? All done? ? FFR = 0.68

Physiologic Guidance 1. Appropriate need for Stents 2. Objective info re ischemia 3. Eliminates operator uncertainty

FAME – 5yr F/U Nunen LX et al. Lancet, August 30, 2015 MACE Death Myoc Infarct Revascularization

FAME 2: Two Year Follow-Up Two year rate of primary endpoint: Death, MI, Urgent Revascularization De Bruyne, et al. NEJM 2014;371:

65 yo M, chest pain at rest and with exertion, ETT (ECG alone) positive at 8’ with minimal ST changes

FFR LAD Ostial Lesion = 0.77

FFR and Appropriate use Criteria. Moving to supported Decisions Prox LAD

iFR vs FFR: The Advise II study - International, Multicenter Study (ADenosine Vasodilator Independent Stenosis Evaluation II Escand J, JACC Interven 2015;8: IFR

Stable Coronary Artery Disease Symptoms of Ischemia Moderate/Severe Stenosis Evidence of ischemia New ECG changes Stress testing or FFR Acute Coronary syndrome - Evidence of ischemia - Stenosis, mild-severe ECG +/- WM abn FFR not needed in culprit, may help in non-culprit Components of PCI indications: Should FFR be part of every PCI?